Fred E Cohen Insider Trading Transactions
Get free email notifications about insider trading for Fred E Cohen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Fred E Cohen. Fred E Cohen is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in GENOMIC HEALTH INC ($GHDX) and Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in CareDx, Inc. ($CDNA) and Director in VERACYTE, INC. ($VCYT) and Director in TANDEM DIABETES CARE INC ($TNDM) and Director in Roka BioScience, Inc. ($ROKA) and Director in Progyny, Inc. ($PGNY) and Director in Intellia Therapeutics, Inc. ($NTLA) and Director in UroGen Pharma Ltd. ($URGN).
Latest Insider Trading Transactions of Fred E Cohen
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BCRX, CDNA, FPRX, GHDX, NTLA, PGNY, ROKA, TNDM, URGN, VCYT
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2021 | URGN | UroGen Pharma Ltd. | Cohen Fred E | Director | Option Exercise | A | 17.98 | 10,000 | 179,800 | 10,000 | |
Jan 22 2021 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Option Exercise | M | 13.78 | 20,000 | 275,600 | 18,000 | |
Jan 22 2021 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Buy | M | 13.78 | 20,000 | 275,600 | 30,000 | 10 K to 30 K (+200.00 %) |
Jan 06 2021 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | M | 14.74 | 15,000 | 221,100 | 0 | |
Jan 06 2021 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Buy | M | 14.74 | 15,000 | 221,100 | 105,893 | 90.9 K to 105.9 K (+16.50 %) |
Oct 27 2020 | PGNY | Progyny, Inc. | Cohen Fred E | Director | Option Exercise | A | 27.95 | 894 | 24,987 | 894 | |
Oct 27 2020 | PGNY | Progyny, Inc. | Cohen Fred E | Director | Option Exercise | A | 27.95 | 27,000 | 754,650 | 27,000 | |
Oct 27 2020 | PGNY | Progyny, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Oct 20 2020 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Option Exercise | M | 7.60 | 10,000 | 76,000 | 0 | |
Oct 20 2020 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Buy | M | 7.60 | 10,000 | 76,000 | 10,000 | 0 to 10 K |
Sep 22 2020 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | M | 4.95 | 9,745 | 48,238 | 0 | |
Sep 22 2020 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | M | 5.49 | 6,679 | 36,668 | 0 | |
Sep 22 2020 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Buy | M | 4.95 | 9,745 | 48,238 | 90,893 | 81.1 K to 90.9 K (+12.01 %) |
Sep 22 2020 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Buy | M | 5.49 | 6,679 | 36,668 | 81,148 | 74.5 K to 81.1 K (+8.97 %) |
Sep 22 2020 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | M | 4.95 | 9,745 | 48,238 | 0 | |
Sep 22 2020 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | M | 5.49 | 6,679 | 36,668 | 0 | |
Sep 22 2020 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Buy | M | 4.95 | 9,745 | 48,238 | 90,893 | 81.1 K to 90.9 K (+12.01 %) |
Sep 22 2020 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Buy | M | 5.49 | 6,679 | 36,668 | 81,148 | 74.5 K to 81.1 K (+8.97 %) |
Jun 19 2020 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | A | 31.35 | 4,978 | 156,060 | 4,978 | |
Jun 19 2020 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | A | 31.35 | 4,978 | 156,060 | 4,978 | |
Jun 19 2020 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 3,190 | 0 | 74,469 | 71.3 K to 74.5 K (+4.48 %) |
Jun 19 2020 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 3,190 | 0 | 74,469 | 71.3 K to 74.5 K (+4.48 %) |
Jun 19 2020 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Option Exercise | A | 20.72 | 19,000 | 393,680 | 19,000 | |
Jun 10 2020 | URGN | UroGen Pharma Ltd. | Cohen Fred E | Director | Option Exercise | A | 28.24 | 10,000 | 282,400 | 10,000 | |
Jun 09 2020 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Option Exercise | A | 26.30 | 10,000 | 263,000 | 10,000 | |
Jun 09 2020 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Option Exercise | A | 26.30 | 10,000 | 263,000 | 10,000 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | D | 52.41 | 6,583 | 345,015 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | D | 51.72 | 10,000 | 517,200 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | D | 31.53 | 10,000 | 315,300 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | D | 52.41 | 6,583 | 345,015 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | D | 26.18 | 10,000 | 261,800 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | D | 51.72 | 10,000 | 517,200 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | D | 36.04 | 1,515 | 54,601 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | D | 31.53 | 10,000 | 315,300 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | D | 35.87 | 8,250 | 295,928 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | D | 26.18 | 10,000 | 261,800 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | D | 0.00 | 6,068 | 0 | 0 | 6.1 K to 0 (-100.00 %) |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | D | 36.04 | 1,515 | 54,601 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | D | 0.00 | 955 | 0 | 0 | 955 to 0 (-100.00 %) |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | D | 35.87 | 8,250 | 295,928 | 0 | |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | D | 0.00 | 68,165 | 0 | 955 | 69.1 K to 955 (-98.62 %) |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | D | 0.00 | 6,068 | 0 | 0 | 6.1 K to 0 (-100.00 %) |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | D | 0.00 | 955 | 0 | 0 | 955 to 0 (-100.00 %) |
Nov 14 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | D | 0.00 | 68,165 | 0 | 955 | 69.1 K to 955 (-98.62 %) |
Oct 03 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 67.28 | 185 | 12,447 | 69,120 | 68.9 K to 69.1 K (+0.27 %) |
Aug 05 2019 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Option Exercise | M | 7.94 | 10,000 | 79,400 | 0 | |
Aug 05 2019 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Option Exercise | M | 5.28 | 10,000 | 52,800 | 0 | |
Aug 05 2019 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Option Exercise | M | 10.41 | 10,000 | 104,100 | 0 | |
Aug 05 2019 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Option Exercise | M | 13.19 | 10,000 | 131,900 | 0 | |
Aug 05 2019 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Buy | M | 7.94 | 10,000 | 79,400 | 40,000 | 30 K to 40 K (+33.33 %) |
Aug 05 2019 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Buy | M | 5.28 | 10,000 | 52,800 | 30,000 | 20 K to 30 K (+50.00 %) |
Aug 05 2019 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Buy | M | 10.41 | 10,000 | 104,100 | 20,000 | 10 K to 20 K (+100.00 %) |
Aug 05 2019 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Buy | M | 13.19 | 10,000 | 131,900 | 10,000 | 0 to 10 K |
Jul 15 2019 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | M | 5.02 | 5,255 | 26,380 | 0 | |
Jul 15 2019 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | M | 5.85 | 5,255 | 30,742 | 0 | |
Jul 15 2019 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | M | 10.00 | 5,255 | 52,550 | 0 | |
Jul 15 2019 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Buy | M | 5.02 | 5,255 | 26,380 | 71,279 | 66 K to 71.3 K (+7.96 %) |
Jul 15 2019 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Buy | M | 5.85 | 5,255 | 30,742 | 66,024 | 60.8 K to 66 K (+8.65 %) |
Jul 15 2019 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Buy | M | 10.00 | 5,255 | 52,550 | 60,769 | 55.5 K to 60.8 K (+9.47 %) |
Jul 03 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 58.86 | 212 | 12,478 | 68,935 | 68.7 K to 68.9 K (+0.31 %) |
Jun 19 2019 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | A | 38.26 | 4,152 | 158,856 | 4,152 | |
Jun 19 2019 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 2,613 | 0 | 55,514 | 52.9 K to 55.5 K (+4.94 %) |
Jun 18 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | A | 52.41 | 6,583 | 345,015 | 6,583 | |
Jun 18 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 0.00 | 955 | 0 | 68,723 | 67.8 K to 68.7 K (+1.41 %) |
Jun 13 2019 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Option Exercise | A | 27.01 | 10,000 | 270,100 | 10,000 | |
Jun 05 2019 | URGN | UroGen Pharma Ltd. | Cohen Fred E | Director | Option Exercise | A | 34.83 | 10,000 | 348,300 | 10,000 | |
May 22 2019 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Option Exercise | A | 15.78 | 19,000 | 299,820 | 19,000 | |
Mar 22 2019 | URGN | UroGen Pharma Ltd. | Cohen Fred E | Director | Option Exercise | M | 16.99 | 15,000 | 254,850 | 25,000 | |
Mar 22 2019 | URGN | UroGen Pharma Ltd. | Cohen Fred E | Director | Buy | M | 16.99 | 15,000 | 254,850 | 15,000 | 0 to 15 K |
Mar 05 2019 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Grant | A | 16.89 | 10,000 | 168,936 | 10,000 | 0 to 10 K |
Mar 05 2019 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Grant | A | 16.89 | 10,000 | 168,936 | 10,000 | 0 to 10 K |
Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | M | 26.01 | 10,000 | 260,100 | 0 | |
Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | M | 26.01 | 10,000 | 260,100 | 0 | |
Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 79.57 | 693 | 55,142 | 67,619 | 68.3 K to 67.6 K (-1.01 %) |
Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 79.57 | 693 | 55,142 | 67,619 | 68.3 K to 67.6 K (-1.01 %) |
Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 78.80 | 9,307 | 733,417 | 68,312 | 77.6 K to 68.3 K (-11.99 %) |
Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 78.80 | 9,307 | 733,417 | 68,312 | 77.6 K to 68.3 K (-11.99 %) |
Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | M | 26.01 | 10,000 | 260,100 | 77,619 | 67.6 K to 77.6 K (+14.79 %) |
Feb 26 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | M | 26.01 | 10,000 | 260,100 | 77,619 | 67.6 K to 77.6 K (+14.79 %) |
Jan 24 2019 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Option Exercise | A | 13.78 | 38,000 | 523,640 | 38,000 | |
Jan 03 2019 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 64.41 | 155 | 9,984 | 67,619 | 67.5 K to 67.6 K (+0.23 %) |
Nov 19 2018 | TNDM | TANDEM DIABETES CA ... | Cohen Fred E | Director | Option Exercise | A | 33.12 | 25,000 | 828,000 | 25,000 | |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | M | 27.75 | 10,000 | 277,500 | 0 | |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 89.50 | 403 | 36,068 | 67,464 | 67.9 K to 67.5 K (-0.59 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 88.73 | 4,200 | 372,678 | 67,867 | 72.1 K to 67.9 K (-5.83 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 87.98 | 3,816 | 335,715 | 72,067 | 75.9 K to 72.1 K (-5.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 85.67 | 745 | 63,823 | 75,883 | 76.6 K to 75.9 K (-0.97 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 84.90 | 836 | 70,978 | 76,628 | 77.5 K to 76.6 K (-1.08 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | M | 27.75 | 10,000 | 277,500 | 77,464 | 67.5 K to 77.5 K (+14.82 %) |
Oct 03 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 70.18 | 142 | 9,966 | 67,464 | 67.3 K to 67.5 K (+0.21 %) |
Sep 10 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | M | 34.44 | 8,250 | 284,130 | 0 | |
Sep 10 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 61.51 | 8,250 | 507,453 | 67,322 | 75.6 K to 67.3 K (-10.92 %) |
Sep 10 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | M | 34.44 | 8,250 | 284,130 | 75,572 | 67.3 K to 75.6 K (+12.25 %) |
Aug 29 2018 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | M | 1.22 | 15,000 | 18,300 | 0 | |
Aug 29 2018 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Buy | M | 1.22 | 15,000 | 18,300 | 52,901 | 37.9 K to 52.9 K (+39.58 %) |
Aug 09 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | M | 25.79 | 8,250 | 212,768 | 0 | |
Aug 09 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 56.81 | 1,400 | 79,535 | 67,322 | 68.7 K to 67.3 K (-2.04 %) |
Aug 09 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 56.10 | 6,850 | 384,265 | 68,722 | 75.6 K to 68.7 K (-9.06 %) |
Aug 09 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | M | 25.79 | 8,250 | 212,768 | 75,572 | 67.3 K to 75.6 K (+12.25 %) |
Jul 03 2018 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | A | 14.74 | 15,000 | 221,100 | 15,000 | |
Jul 03 2018 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 5,000 | 0 | 37,901 | 32.9 K to 37.9 K (+15.20 %) |
Jul 03 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 50.40 | 198 | 9,979 | 67,322 | 67.1 K to 67.3 K (+0.29 %) |
Jun 22 2018 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Option Exercise | A | 6.09 | 30,000 | 182,700 | 30,000 | |
Jun 11 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | A | 51.72 | 10,000 | 517,200 | 10,000 | |
Jun 07 2018 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Option Exercise | A | 7.60 | 10,000 | 76,000 | 10,000 | |
Apr 03 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 31.29 | 319 | 9,982 | 67,124 | 66.8 K to 67.1 K (+0.48 %) |
Dec 05 2017 | TNDM | TANDEM DIABETES CA ... | Cohen Fred E | Director | Option Exercise | A | 2.59 | 5,300 | 13,727 | 5,300 | |
Nov 17 2017 | TNDM | TANDEM DIABETES CA ... | Cohen Fred E | Director | Option Exercise | A | 2.54 | 1,700 | 4,318 | 1,700 | |
Nov 13 2017 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | A | 5.49 | 6,679 | 36,668 | 6,679 | |
Nov 13 2017 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | D | 12.40 | 10,948 | 135,755 | 0 | |
Oct 03 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 32.09 | 311 | 9,980 | 66,513 | 66.2 K to 66.5 K (+0.47 %) |
Sep 20 2017 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Option Exercise | M | 4.27 | 54,250 | 231,648 | 0 | |
Sep 20 2017 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Sell | S | 5.42 | 54,250 | 294,035 | 119,410 | 173.7 K to 119.4 K (-31.24 %) |
Sep 20 2017 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Buy | M | 4.27 | 54,250 | 231,648 | 173,660 | 119.4 K to 173.7 K (+45.43 %) |
Jul 14 2017 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | A | 1.22 | 15,000 | 18,300 | 15,000 | |
Jul 14 2017 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 5,000 | 0 | 32,901 | 27.9 K to 32.9 K (+17.92 %) |
Jul 05 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 32.55 | 307 | 9,993 | 66,202 | 65.9 K to 66.2 K (+0.47 %) |
Jun 30 2017 | ROKA | Roka BioScience, I ... | Cohen Fred E | Director | Option Exercise | A | 2.55 | 3,000 | 7,650 | 3,000 | |
Jun 20 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | A | 31.53 | 10,000 | 315,300 | 10,000 | |
Jun 07 2017 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Option Exercise | A | 7.94 | 10,000 | 79,400 | 10,000 | |
Jun 02 2017 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Grant | A | 5.15 | 1,941 | 9,996 | 119,410 | 117.5 K to 119.4 K (+1.65 %) |
May 25 2017 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Option Exercise | A | 5.13 | 30,000 | 153,900 | 30,000 | |
May 23 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | M | 14.37 | 8,250 | 118,553 | 0 | |
May 23 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 29.54 | 8,250 | 243,745 | 65,895 | 74.1 K to 65.9 K (-11.13 %) |
May 23 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | M | 14.37 | 8,250 | 118,553 | 74,145 | 65.9 K to 74.1 K (+12.52 %) |
May 22 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | M | 17.59 | 8,250 | 145,118 | 0 | |
May 22 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
May 22 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 29.88 | 16,500 | 493,040 | 65,895 | 82.4 K to 65.9 K (-20.03 %) |
May 22 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | M | 17.59 | 8,250 | 145,118 | 82,395 | 74.1 K to 82.4 K (+11.13 %) |
May 22 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | M | 18.50 | 8,250 | 152,625 | 74,145 | 65.9 K to 74.1 K (+12.52 %) |
May 18 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | M | 18.13 | 8,250 | 149,573 | 0 | |
May 18 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 30.68 | 8,250 | 253,102 | 65,895 | 74.1 K to 65.9 K (-11.13 %) |
May 18 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | M | 18.13 | 8,250 | 149,573 | 74,145 | 65.9 K to 74.1 K (+12.52 %) |
Apr 04 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 31.49 | 317 | 9,982 | 65,895 | 65.6 K to 65.9 K (+0.48 %) |
Mar 02 2017 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Grant | A | 6.24 | 1,602 | 9,996 | 117,469 | 115.9 K to 117.5 K (+1.38 %) |
Jan 04 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 29.39 | 340 | 9,993 | 65,578 | 65.2 K to 65.6 K (+0.52 %) |
Jan 04 2017 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 3,391 | 0 | 22,630 | 19.2 K to 22.6 K (+17.63 %) |
Dec 02 2016 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Grant | A | 5.59 | 1,788 | 9,995 | 115,867 | 114.1 K to 115.9 K (+1.57 %) |
Nov 16 2016 | TNDM | TANDEM DIABETES CA ... | Cohen Fred E | Director | Option Exercise | A | 1.90 | 17,000 | 32,300 | 17,000 | |
Oct 04 2016 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 28.92 | 345 | 9,977 | 65,238 | 64.9 K to 65.2 K (+0.53 %) |
Oct 04 2016 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 2,643 | 0 | 19,239 | 16.6 K to 19.2 K (+15.93 %) |
Sep 06 2016 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Grant | A | 4.11 | 2,433 | 10,000 | 114,079 | 111.6 K to 114.1 K (+2.18 %) |
Jul 19 2016 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | A | 4.95 | 9,745 | 48,238 | 9,745 | |
Jul 19 2016 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 5,000 | 0 | 16,596 | 11.6 K to 16.6 K (+43.12 %) |
Jul 06 2016 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 26.74 | 373 | 9,974 | 64,893 | 64.5 K to 64.9 K (+0.58 %) |
Jul 06 2016 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 2,695 | 0 | 11,596 | 8.9 K to 11.6 K (+30.28 %) |
Jun 24 2016 | ROKA | Roka BioScience, I ... | Cohen Fred E | Director | Option Exercise | A | 0.68 | 30,000 | 20,400 | 30,000 | |
Jun 20 2016 | VCYT | VERACYTE, INC. | Cohen Fred E | Director | Option Exercise | A | 5.28 | 10,000 | 52,800 | 10,000 | |
Jun 20 2016 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | A | 5.02 | 5,255 | 26,380 | 5,255 | |
Jun 14 2016 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | A | 26.18 | 10,000 | 261,800 | 10,000 |